Mass-spectrometric and bioinformatic analysis of eEF1Bγ interactome in the cytoplasmic fraction of A549 cells by Kapustian, L.M. et al.
292
L. M. Kapustian, I. L. Lysetsky, T. V. Bondarchuk
©  2018 L. M. Kapustian et al.; Published by the Institute of Molecular Biology and Genetics, NAS of Ukraine on behalf of Bio-
polymers and Cell. This is an Open Access article distributed under the terms of the Creative Commons Attribution License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, 
provided the original work is properly cited
UDC 577.217.535 + 577.322.23
Mass-spectrometric and bioinformatic analysis of eEF1Bγ 
interactome in the cytoplasmic fraction of A549 cells
L. M. Kapustian, I. L. Lysetsky, T. V. Bondarchuk, O. V. Novosylna, B. S. Negrutskii
Institute of Molecular Biology and Genetics, NAS of Ukraine 
150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03143 
negrutskii@imbg.org.ua
Aim. To study protein networks containing the translation elongation factor eEF1B gamma 
(eEF1Bγ) in lung carcinoma cells. Methods. The protein partners of eEF1Bγ in the cytoplas-
mic fraction of human lung adenocarcinoma A549 cells were identified by co-immunoprecip-
itation (co-IP) followed by subsequent liquid chromatography-tandem mass spectrometry 
(LC-MS/MS). The protein interaction network for eEF1Bγ was determined by a Cytoscape 
3.2.0 program using a MCODE plugin. Results. 222 high-scored proteins interacting with 
eEF1Bγ in the cytoplasm of A549 cells have been identified. Possible functional networks 
involving these protein-protein interactions were predicted using bioinformatic approaches. 
Conclusions. Five protein networks were identified as possible targets of eEF1Bγ in lung 
cancer cells. Apart from translation, eEF1Bγ was shown to be potentially involved in cell 
cycle regulation, nucleosome remodeling, transcription, mRNA splicing and processing, and 
oxidative stress response.
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Introduction
eEF1Bg is a non-catalytic subunit of the 
eEF1B complex responsible for GDP/GTP 
exchange in translation elongation factor 
eEF1A. Apart from eEF1Bg, eEF1B contains 
two catalytic subunits, eEF1Bα and eEF1Bβ. 
Altogether eEF1A and the eEF1B complex 
provide efficient and accurate translation of 
mRNA on ribosomes in cytoplasm of eukary-
otic cells. However, the data on the existence 
of a free pool of the eEF1B subunits in human 
cancer tissues [1.2] suggested their non-trans-
lational functioning as well. The nature of 
these non-canonical functions remains mostly 
unidentified. 
Recently, the information on cellular pro-
cesses that can engage the oncogenic eEF1Bβ 
subunit in cancer cells has been obtained [3, 4]. 
While a direct information about an onco-
genic role of the eEF1Bg subunit is absent, 
there are several reports on its overexpression 
in cancer cells [5–8]. This suggests a possibil-
ity of cancer-related functioning of this pro-
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tein. Here, we used the combination of co-
immunoprecipitation, mass-spectrometry and 
bioinformatics to investigate a cytoplasmic 
interactome of the eEF1Bg protein in human 
cancer cells. In particular, we aimed to shed 
light on non-translational cancer-related pro-
cesses which can involve eEF1Bg in lung 
cancer. 
The obtained results show that eEF1Bγ may 
be involved in cell cycle regulation, nucleo-
some remodeling, mRNA splicing and process-
ing, viral mRNA transcription and oxidative 
stress response in lung cancer cells.
Materials and Methods
Preparation of cytoplasmic fraction 
of human lung cells
Human lung cancer cells A-549 were har-
vested with Trypsin-EDTA. Cytoplasmic 
fraction was isolated as in [3]. Briefly, the 
cells were lysed with 1.5 volume of buffer 
containing 10 mM HEPES pH7.9, 1.5 mM 
MgCl2, 0.5 % NP-40, 0.2 mM PMSF, 0.5 mM 
DTT and kept on ice for 20 min. Then, the 
cells were centrifuged 10 min at 400 g. The 
supernatant was subjected to centrifugation 
at 16000 g for 30 min. The obtained super-
natant was used as cytoplasmic extract. The 
absence of nuclear fraction admixture was 
verified by Western blotting with anti-
Poly(ADP-ribose) polymerase and anti-His-
tone 3.3 antibodies.
Co-immunoprecipitation
The cytoplasmic extract was pre-cleared with 
Protein G Sepharose (Sigma, USA) for 1 h at 
4 °C. Anti-eEF1Bγ antibodies (Abnova, 
Taiwan) (1.5 μg of antibodies per 1 mg of 
total protein) were added to pre-cleared lysates 
and incubated overnight at 4 °C. After addition 
of Protein G Sepharose slurry the incubation 
persisted for 2 h at 4 °C with continuous shak-
ing. Then the resin was washed with ten resin 
volumes of the lysis buffer and treated further 
in accordance with the manufacturer’s proto-
col. After elution of eEF1Bγ-associated pro-
teins, the 12 % PAGE was performed [9]. The 
protein bands of interest were cut and pro-
cessed for mass-spectrometry analysis 
(LC-MS/MS).
Mass-spectrometry LC-MS/MS
The cytoplasmic extract incubated with plain 
G-Sepharose was used as a control of nonspe-
cific binding. The electrophoretic bands that 
were not present in the control or were much 
more extensive than in the control were cut 
and processed for mass spectrometry analysis 
at the Mass Spectrometry Laboratory of the 
Institute of Biochemistry and Biophysics 
(Warsaw, Poland) using LTQ-Orbitrap Velos 
mass spectrometer (Thermo Scientific) 
equipped with nanoAcquity (Waters 
Corporation) LC system, with ions score or 
expect cut-off, 30 and significance threshold, 
p < 0.05, as described before [3, 4]. 
Bioinformatics analysis
Cytoscape 3.2.0 Program [10] interaction da-
tabase BIOGRID was supplemented with 
newly identified protein partners of eEF1Bγ 
and analyzed by MCODE plugin which finds 
highly interconnected regions (clusters) in any 
network loaded into Cytoscape. These clusters 
have been shown to represent protein com-
plexes and/or parts of pathways [11]. For the 
sake of clarity, such known protein partners of 
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eEF1Bγ as eEF1A1, eEF1A2 and UBC (poly-
ubiquitin-C) were excluded from the database 
as they interact with a huge number of cell 
proteins and create a very complicated network 
of protein-protein interactions that is not as-
sociated with eEF1Bγ directly [3]. Also, we 
simplified the task by taking for analysis only 
the first (direct) partners of eEF1Bγ partners 
determined by the Program algorithm. MCODE 
analysis was performed on the hybrid super-
computer “SCIT-4” at the Glushkov Institute 
of Cybernetics (GIC) of National Academy of 
Sciences of Ukraine (http://icybcluster.org.ua).
Results and Discussion
Literature data indicate that eEF1Bg may have 
connections with different types of cytoske-
leton [12, 13] and interact with viral compo-
nents [14, 15], it may be involved in transcrip-
tion process [16–18] and oxidative stress re-
sponse [19]. 
Our study was aimed to examine whether 
these and other cellular processes implicate 
eEF1Bγ in lung cancer cells. We identified 222 
proteins as the interacting partners of eEF1Bγ 
in the cytoplasm of human lung adenocarci-
noma A549 cells by using co-immunoprecip-
itation and subsequent LC-MS/MS identifica-
tion of the interacting proteins. These protein 
partners were used for further analysis by the 
Cytoscape program to predict functional clus-
ters, which may involve these proteins. 
First, human BioGRID database was em-
ployed to generate by the MCODE the protein 
interaction network of eEF1Bγ based on exist-
ing (published) data. The resulting network 
contained 11 proteins (including eEF1Bγ). 
Three of them showed direct interactions with 
eEF1Bγ (Fig. 1). Those are eEF1Bβ (Gene 
ID 1936), FLNC (filamin C, gamma, Gene 
ID 2318) and NUDT21 (Cleavage and poly-
adenylation specificity factor subunit 5, Gene 
Fig. 1. Protein cluster containing 
eEF1Bγ, generated by MCODE in 
the Cytoscape 3.2.0 Program from 
Human BioGRID database solely on 
the basis of literature data.
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ID 11051). The other members of this protein 
network are: SKIV2L2 (Ski2 Like RNA 
Helicase 2, Gene ID 23517), TERF1 (Telomeric 
repeat-binding factor 1, Gene ID 7014), TAF2 
(TATA-box binding protein associated factor 2, 
Gene ID 6873), TBP (TATA-box binding pro-
tein, Gene ID 6908), ELF3 (ETS-related tran-
scription factor Elf-3, Gene ID 1999), JAK1 
(Janus kinase 1, Gene ID 3716) and ATIC 
(5-aminoimidazole-4-carboxamide ribonucle-
otide formyltransferase/IMP cyclohydrolase, 
Gene ID 471). The majority of these proteins 
participate in synthesis and degradation of 
mRNA and its regulation (20–24). 
Second, a protein network was generated 
by MCODE after complementing the BioGrid 
database with newly identified 222 partners of 
eEF1Bγ. Resulting protein cluster contained 
55 proteins (including eEF1Bγ) (Fig. 2). 
Several functional protein sub-clusters were 
identified among the main cluster. Sub-
cluster A included the proteins associated with 
mRNA splicing and processing. Sub-cluster B 
contained the proteins participating in nucleo-
some remodeling via changes of post-transla-
tional modifications of histones and DNA bind-
ing. The proteins from sub-cluster C were 
involved in cell cycle events. Sub-cluster D 
mostly comprised the members of translation 
apparatus, and sub-cluster E contained the 
transcription factors associated with oxidative 
stress response. The detailed analysis of the 
Fig. 2. Protein cluster containing 
eEF1Bγ, generated by MCODE in 
the Cytoscape 3.2.0 Program from 
Human BioGRID database supple-
mented with co-IP/MS-MS experi-
mental data. Sub-clusters: A — the 
proteins associated with mRNA 
splicing and processing, B — nucleo-
some remodeling which proceeds 
via changes in the post-translational 
modifications of histones, C — the 
proteins involved in cell cycle 
events, D — translation and viral 
RNA replication, E – oxidative stress 
response. 
B
D
C
E
A
296
L. M. Kapustian, I. L. Lysetsky, T. V. Bondarchuk et al.
protein components of the sub-clusters is 
shown below.
Sub-cluster A contained 3 experimentally 
identified in this paper protein partners of 
eEF1Bγ — DDX5 (Probable ATP-dependent 
RNA helicase DDX5, Gene ID 1655), 
SYNCRIP (Heterogeneous nuclear ribonu-
cleoprotein Q, Gene ID 10492) and U2AF2 
(Splicing factor U2AF 65 kDa subunit, Gene 
ID 11338) . The proteins CDC5L (Cell divi-
sion cycle 5-like, Gene ID 988), SRRM1 
(Serine/arginine repetitive matrix 1, Gene 
ID 10250), SNRPD1 (Small nuclear ribonu-
cleoproteinD1polypeptide 16 RDa, Gene 
ID 6632), PRPF19 (Pre-mRNA processing 
factor 19, Gene ID 27339), rev P19 (Protein 
Rev p19, Gene ID 155908) and SNPD2 (Small 
nuclear ribonucleoprotein D2 polypeptide 
16.5 kDa, Gene ID 6633) formed the central 
core of sub-cluster A. The outer layer of this 
group contained the proteins HNRNPR 
(Heterogeneous nuclear ribonucleoprotein R, 
Gene ID 10236), SF3A (Splicing factor 3A, 
subunit 1, Gene ID 10291), EFTUD2 
(Elongation factor Tu GTP binding domain 
containing 2, Gene ID 9343), SSBP1 (Single 
stranded DNA binding protein 1, Gene 
ID 6742), PRPF8 (Pre-mRNA processing fac-
tor 8, Gene ID 10594), PRPF6 (Pre-mRNA 
processing factor 6, Gene ID 24148), YBX3 
(Y box binding protein 3, Gene ID 8531), 
TADA2A (Transcriptional adaptor 2A, Gene 
ID 6871), SYNCRIP (Heterogeneous nuclear 
ribonucleoprotein Q, Gene ID 10492), U2AF2 
(U2 small nuclear RNA auxiliary factor 2, 
Gene ID 11338), DDX5 (Probable ATP-
dependent RNA helicase DDX5, Gene 
ID 1655), and C14orf166 (Chromosome 14 
Open Reading Frame 166, Gene ID 51637).
Association of eEF1Bγ with sub-cluster A 
suggests its participation in the mRNA splicing 
and processing events. Peculiarly, the splicing 
complexes are normally localized in the nu-
cleus, whereas the interaction of eEF1Bγ with 
the members of sub-cluster A is observed in 
the cytoplasmic fraction of the cells. One of 
the possible explanation is that eEF1Bγ par-
ticipates in cyto-nuclear transport of the com-
ponents of the sub-cluster A. As indicated in 
the Materials and Methods section, the absence 
of admixture of the nuclear proteins in the 
cytoplasmic fraction was routinely controlled 
by Western blotting with anti-Poly(ADP-ri-
bose) polymerase and anti-Histone 3.3 anti-
bodies. This significantly diminishes the pos-
sibility of artefact presence of the components 
of the splicing machinery in cytoplasm. 
According to bioinformatics analysis, sub-
cluster B is linked to sub-cluster A via several 
proteins: СHD4 (Chromodomain helicase 
DNA binding protein 4, Gene ID 1108), MTA2 
(Metastasis associated 1 family, member 2, 
Gene ID 9219) and MBD3 (Methyl-ChG bind-
ing domain protein 3, Gene ID 53615). There 
are six more proteins in this sub-cluster: 
NR2C1 (Nuclear receptor subfamily 2, 
group C, member 1, Gene ID 7181), RBBP7 
(Retinoblastoma Binding Protein 7, Gene 
ID 5931), KDM5B (Lysine-specific demeth-
ylase 5B, Gene ID 10765), MTA3 (metastasis 
associated 1 family, member 3, Gene 
ID 57504), GATAD2A (GATA zinc finger do-
main containing 2A, Gene ID 54815), and 
SOX2 (SRY (Sex determining region Y)-box 
2, Gene ID 6657). The main function of sub-
cluster B is suggested to be a nucleosome re-
modeling which proceeds via changes in the 
post-translational modifications of histones. 
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Thus, eEF1Bγ can be possibly involved in 
controlling the pre-translational gene expres-
sion events.
The proteins SOX2 and MTA3 function-
ally link sub-clusters B and C. The core of 
sub-cluster C contains five proteins: CCNB1 
(cyclin B1, Gene ID 891), CDC16 (Cell 
Division Cycle 16, Gene ID 8881), ANAPC1 
(Anaphase Promoting Complex Subunit 1, 
Gene ID 64682), ANAPC4 (Anaphase 
Promoting Complex Subunit 4, Gene 
ID 29945), and CDC27 (Cell Division 
Cycle 27, Gene ID 996). All these proteins, 
except cyclin B1, are the components of the 
Anaphase Promoting Complex (APC), which 
maintains the metaphase–anaphase transition 
due to the degradation of cyclin B1. Cyclin 
B1 is associated with G2/M transition of mi-
totic cell cycle. Other two proteins of sub-
cluster C are TP53BP1 (Tumor Protein P53 
Binding Protein 1, Gene ID 7158) and MDC1 
(Mediator of DNA-Damage Checkpoint 1, 
Gene ID 9656). The last one is connected with 
sub-cluster A by two links. Importantly, pos-
sible association of eEF1Bγ with the cell 
cycle regulation components has been re-
ported [25]. 
The protein FBXO5 (F- box protein 5, Gene 
ID 26271), which can inhibit APC complex 
due to its ubiquitin ligase activity, connects 
sub-cluster C with sub-clusters A and D 
through SKP1 (S-phase kinase-associated pro-
tein 1, Gene ID 6500). The SKP1 protein takes 
part in ubiquitination of FBXW4 (F-Box and 
WD Repeat Domain Containing 4, Gene 
ID 6468), which in turn interacts with two 
proteins of sub-cluster A, one of them (DDX5) 
was experimentally identified as a partner of 
eEF1Bγ in this paper.
The protein MAPK14 (mitogen-activated 
protein kinase 14, Gene ID1432) links sub-
clusters C and D. This kinase belongs to the 
family of MAP-kinases, which integrate ubiq-
uitous cellular signals and participate in regu-
lation of transcription, differentiation, prolif-
eration and cell development. MAPK14 is 
implicated in the control of the genotoxic 
stress response and in the stress-induced tran-
scription and cell cycle regulation [26]. 
According to the scheme, in sub-cluster D this 
protein interacts with SKP1 (S-Phase Kinase-
Associated Protein1, Gene ID 6500), which 
participates in regulation of ubiquitination, and 
KARS (lysyl-tRNA synthetase, Gene ID 3735). 
KARS is associated with protein biosynthesis 
and also interacts with gag Pr55 (Gag poly-
protein (Human immunodeficiency virus 1), 
Gene ID 155030). KARS interaction with gag 
Pr55 assists effective packaging of tRNA3Lys, 
which works as a primer for initiation of the 
reverse transcription, to viral particles [27]. 
The protein AIMP2 (Aminoacyl tRNA 
Synthetase Complex-Interact ing 
Multifunctional Protein 2, Gene ID 7965) from 
sub-cluster D interacts with KARS and LARS 
(Leucyl-TRNA Synthetase, Gene ID 51520) 
in the macromolecular aminoacyl-tRNA syn-
thetase complex. Interestingly, another com-
ponent of HIV-1 virus, the protein rev p19, is 
also found in the interactome of eEF1Bγ (sub-
cluster A). Thus, on the non-translational side, 
the data on sub-clusters D and A provide in-
dependent support to the notion that eEF1Bγ 
can take part in functioning of HIV-1 virus 
[14]. In particular, it may play a role of struc-
tural platform for spatial immobilization of 
some viral and host-cell proteins leading to 
more effective viral replication.
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The protein PCK1 (Phosphoenolpyruvate 
Carboxykinase 1, Gene ID 5105) connects 
sub-clusters A, B, C, and E. This protein is at 
the main checkpoint in control of gluconeo-
genesis. PCK1 is linked to sub-cluster A via 
the protein HSPA1L (Heat Shock 70kDa 
Protein 1-Like, Gene ID 5105). PCK1 is con-
nected to sub-claster B through the protein 
C1QBP (Complement Component 1, Q Sub-
com ponent Binding Protein, Gene ID 708), a 
multifunctional protein, associated with in-
flammation and infection processes, apoptosis, 
transcription and pre-mRNA splicing regula-
tion, and ribosome biogenesis [28]. C1QBP 
interacts with the protein SOX2 from sub-
cluster B that links sub-clusters C and B. It 
also interacts with the protein YBX3 (Y Box 
Binding Protein 3, Gene ID 8531) from sub-
cluster A, which can act as a transcription 
factor specifically binding certain DNA se-
quences, in particular ds-DNA. PCK1 is linked 
to sub-cluster E through interaction with the 
proteins ELOC (Elongin-C, Gene ID 6921) 
and ELOB (Elongin-B, Gene ID 6923). ELOC 
and ELOB are the regulatory subunits of the 
transcription factor B (SIII) complex, which 
activates RNA-polymerase II–mediated tran-
scription elongation. Interestingly, eEF1Bγ 
was reported to interact with RNA-poly-
merase II [16].
Sub-cluster E also includes LRR1 (Leucine-
rich repeat protein 1, Gene ID 122769), a 
negative regulator of 4-1BB-mediated signal-
ing, which leads to the NK-kappaB and JNK1 
activation [29]. An independent study showed 
that eEF1Bγ is a positive regulator of NF-
кappaB signaling pathway, with unknown 
mechanism of action [17]. Another component 
of this sub-cluster E is HIF1A (Hypoxia 
Inducible Factor 1, Alpha Subunit (Basic 
Helix-Loop-Helix Transcription Factor, Gene 
ID 3091), a subunit of transcription factors 
complex HIF-1, which is a main regulator of 
anti-hypoxic homeostatic cell response. This 
factor is responsible for the transcription acti-
vation of many genes involved in energetic 
metabolism, angiogenesis, apoptosis as well 
as of the genes that product an enhanced oxy-
gen transition or raise anti-hypoxic metabolic 
adaptation level [30]. The protein EPAS1 
(Endothelial PAS Domain Protein 1, Gene 
ID 2034) is a link between HIF1A and ELOB. 
This protein is a transcription factor associ-
ated with induction of the genes regulated by 
oxygen. The protein FEM1B (Fem-1 
Homolog B, Gene ID 10116) belongs to a 
family of death receptor-associated proteins 
essential for apoptosis. Thus, sub-cluster E 
mainly contains the transcription factors par-
ticipating in the induction of the oxidative 
stress response, which can play adaptive or 
apoptotic role. 
Several papers suggested possible participa-
tion of eEF1Bγ in oxidative stress response 
[19, 31, 32], however the details of such con-
nection were not presented. Our data predict 
existence of the direct links between eEF1Bγ 
and transcription factors involved in induction 
of this response. This connection can be used 
as a new target for drugs with a capacity of 
jugulating oxidative stress response in human 
cells. 
Translation initiation factor eIF1B (sub-
cluster D) interacts with transcription factor 
ELOC (sub-cluster E) and with translation 
initiation factor eIF3L (Eukaryotic Translation 
Initiation Factor 3, Subunit L, Gene ID 51386). 
Factor eIF3L interacts with eEF1Bγ closing 
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the loop of interactions in sub-cluster D. On 
the other hand, eIF3L interacts with TADA2A 
(sub-cluster A) which is a member of the his-
tone-acetylase complex PCAF. It is one more 
link that connects eEF1Bγ with sub-cluster A, 
the function of which is associated with the 
nucleosome structure modification. 
Several identified protein partners of 
eEF1Bγ are associated with human diseases. 
The proteins CCNB1 and FBXO5 from sub-
cluster C are associated with tetraploidy [33]. 
The proteins CCNB1, MDC1 and MTA3 (sub-
cluster C) are linked to breast cancer [34–36]. 
The protein PRPF8 (sub-cluster A) is related 
to myeloid neoplasms [37]. The proteins 
CDC5L and PRPF19 from sub-cluster A par-
ticipate in the development of poikiloderma 
with neutropenia [38]. The proteins CDC27 
(sub-cluster C) and SSBP1 (sub-cluster A) are 
associated with herpes infection [39,40]. The 
proteins MAPK14 (sub-cluster D) and HIF1A 
(sub-cluster E) are involved in vascular disease 
[41, 42]. DDX5 (sub-cluster A) participates in 
the necrosis development [43].
Surprisingly, seven proteins from sub-clus-
ters A, B, C and protein PCK1, which connects 
these sub-clusters, are involved in corneal 
diseases, particularly retinoblastoma. It opens 
an interesting possibility of the eEF1Bγ in-
volvement in the development of human cor-
neal diseases. 
As eEF1Bγ has no evident catalytic activ-
ity, we suggest that the potential molecular 
mechanisms of its participation in non-trans-
lational events could involve its ability to form 
multimeric structures. In such way, eEF1Bγ 
can serve as a scaffold for various protein 
partners participating in a variety of cellular 
processes.
Conclusions
222 proteins were identified by co-immuno-
precipitation, with subsequent LC-MS-MS, as 
interacting with eEF1Bγ in the cytoplasm of 
human lung adenocarcinoma A549 cells. The 
eEF1Bγ protein partners were used to construct 
possible functional networks by the Cytoscape 
3.2.0 program. We identified five protein net-
works (sub-clusters), which can involve 
eEF1Bγ in human cancer cells. They are linked 
to mRNA splicing and processing; nucleosome 
remodeling; cell cycle regulation; viral RNA 
transcription; oxidative stress response. Thus, 
our data support and detail the previously re-
ported cases of eEF1Bγ linkage to the pro-
cesses of cell cycle, transcription of viral 
RNAs and oxidative stress response. Moreover, 
they indicate, for the first time, a possible 
participation of eEF1Bγ in the mRNA matura-
tion and nucleosome remodeling in human 
cancer cells.
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Мас-спектрометричний та біоінформаційний 
аналіз інтерактома eEF1Bγ в цитоплазматичній 
фракції клітин A549
Л. М. Капустян, І. Л. Лисецький, Т. В. Бондарчук, 
О. В. Новосильна, Б. С. Негруцький
Мета. Виявити білкові мережі, до яких може входити 
фактор елонгації трансляції eEF1Bγ в клітинах карци-
номи легені. Методи. Білки-партнери eEF1Bγ у цито-
плазматичній фракції клітин аденокарциноми легені 
людини А549 були ідентифіковані за допомогою ко-
іммунопреципітації із наступною рідинною хромато-
графією та тандемною мас-спектрометрією (LC-MS/
MS). Білкові мережі, до яких входить eEF1Bγ, визна-
чали за допомогою програми Cytoscape 3.2.0 із плагі-
ном MCODE. Результати. Ідентифіковано 222 білки-
партнери eEF1Bγ в цитоплазматичній фракції клітин 
А549. Функціональні мережі, які можуть формуватися 
цими білками, були визначені біоінформатично. 
Висновки. На основі експериментальних даних ви-
найдено п’ять білкових мереж, у яких може брати 
участь eEF1Bγ в клітинах аденокарциноми легені 
людини. Показано, що крім трансляційних компонен-
тів, ці мережі формуються білками, задіяними у регу-
ляції клітинного циклу, ремоделюванні нуклеосом, 
транскрипції, сплайсингу і процесінгу мРНК та клі-
тинної відповіді на оксидативний стрес.
К л юч ов і  с л ов а: eEF1Bγ, білок-білкові взаємодії, 
клітини А549.
Мас-спектрометрический 
и биоинформационный анализ интерактома 
eEF1Bγ в цитоплазматической фракции 
клеток A549
Л. М. Капустян, И. Л. Лисецкий, Т. В. Бондарчук, 
А. В. Новосильная, Б. С. Негруцкий
Цель. Выявить белковые сети, членом которых может 
быть фактор элонгации трансляции eEF1Bγ в клетках 
карциномы легкого. Методы. С помощью ко-иммуно-
преципитации с последующей жидкостной хромато-
графией и тандемной масс-спектрометрией были иден-
тифицированы белки-партнеры eEF1Bγ в цитоплазма-
тической фракции клеток аденокарциномы легкого 
людини А549. Белковые сети, в состав которых входит 
eEF1Bγ, определяли с помощью программы Cytoscape 
3.2.0 с плагином MCODE. Результаты. Иденти фи ци-
ро ваны 222 белка-партнера eEF1Bγ в цитоплазмати-
ческой фракции клеток А549. Функциональные сети, 
которые могут формироваться этими белками, были 
определены биоинформатически. Выводы. На осно-
вании экспериментальных данных найдено пять бел-
кових сетей, в которых может участвовать eEF1Bγ в 
клетках аденокарциномы легкого человека. Показано, 
что кроме трансляционных компонентов, эти сети 
формируются белками, задействованными в регуляции 
клеточного цикла, ремоделировании нуклеосом, транс-
крипции, сплайсинга и процессинга мРНК и клеточ-
ного ответа на оксидативный стресс.
К л юч е в ы е  с л ов а: eEF1Bγ, белок-белковые взає-
модействия, клетки А549.
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